Fig. 2From: Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysisRanking probability of GLP1RAs (Fixed Effects Rankogram)Back to article page